Can-Fite BioPharma Ltd.CANFEarnings & Financial Report
NYSE
CANF Q2 2025 Key Financial Metrics
売上高
$202.0K
粗利益
N/A
営業利益
$-4.9M
純利益
$-4.9M
粗利益率
N/A
営業利益率
-2424.8%
純利益率
-2413.9%
前年比成長
-36.1%
EPS
$0.00
資金フロー
Can-Fite BioPharma Ltd. Q2 2025 Financial Summary
Can-Fite BioPharma Ltd. reported revenue of $202.0K (down 36.1% YoY) for Q2 2025, with a net profit of $-4.9M (down 23.2% YoY) (-2413.9% margin). Cost of goods sold was N/A.
Key Financial Metrics
| Total Revenue | $202.0K |
|---|---|
| Net Profit | $-4.9M |
| Gross Margin | N/A |
| Operating Margin | -2424.8% |
| Report Period | Q2 2025 |
Can-Fite BioPharma Ltd. Quarterly Revenue & Net Profit History
Can-Fite BioPharma Ltd. quarterly results over the last 2 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q2 2025 | $202.0K | -36.1% | $-4.9M | -2413.9% |
| Q2 2024 | $316.0K | -19.4% | $-4.0M | -1252.2% |
損益計算書
| Q2 2024 | Q2 2025 | |
|---|---|---|
| 売上高 | $316000 | $202000 |
| 前年比成長 | -19.4% | -36.1% |
貸借対照表
| Q2 2024 | Q2 2025 | |
|---|---|---|
| 総資産 | $5.9M | $7.7M |
| 総負債 | $3.4M | $3.5M |
| 株主資本 | $2.5M | $4.2M |
キャッシュフロー
| Q2 2024 | Q2 2025 | |
|---|---|---|
| 営業CF | $-4.0M | $-4.8M |